< Back to News

October 2019 TGA SAS Category B Approvals

November 18, 2019

October was another month of increasing approvals for Special Access Scheme Category B (SAS-B) medical cannabis patients in Australia, with 3,594 approvals issued.

Medical cannabis awareness in this country continues to grow as patient numbers increase month-on-month. Australian patients are continuing to seek access to medical cannabis by enquiring through their allied health professionals.

MedReleaf Australia’s Clinical Support Team are available to provide continual education to our allied health groups on the wide therapeutic use of medical cannabis and how to access it.